Skip to main content
logo
Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
13.97
-0.04 (-0.29%)
Sep 15, 2026, 3:00 PM CST

SHA:600535 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,2231,105955.591,071-264.242,359
Depreciation & Amortization
422.65447.57496.2504.91517.95487.77
Other Amortization
47.4517.046.311.2314.7315.23
Loss (Gain) From Sale of Assets
-1.77-8.61-2.11-0.15-1.48-44.22
Asset Writedown & Restructuring Costs
56.6956.95218.011.78352.26265.48
Loss (Gain) From Sale of Investments
116.116.74198.5270.751,158-1,682
Provision & Write-off of Bad Debts
2.4420.88-0.238.19-1.34-5.35
Other Operating Activities
-109.82-55.15-72.94-2.03-31.24123.82
Change in Accounts Receivable
-271.05-522.6878.221,243535.511,231
Change in Inventory
114.76268.4618.32-220.72-2.86-198.37
Change in Accounts Payable
205.8666.85121.58-395.3536.56243.78
Change in Other Net Operating Assets
---67.7611.013.44
Operating Cash Flow
1,8061,4252,0152,5762,2802,801
Operating Cash Flow Growth
-5.84%-29.28%-21.78%12.98%-18.62%56.39%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-265.17-381.26-564.94-668.82-404.41-571.73
Sale of Property, Plant & Equipment
1.89627.581.191.3468.92
Cash Acquisitions
------147.31
Divestitures
-83.38---424.19
Investment in Securities
-207.5-209.9-382.07-134.14-919.91126.42
Other Investing Activities
138.2855.3-21.49-1,30756.7556.76
Investing Cash Flow
-338.61-446.48-940.87-2,109-1,266-42.83

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-9701,052213.91102.791
Long-Term Debt Issued
-884.391,4511,8172,7111,441
Total Debt Issued
1,3591,8542,5042,0312,8141,442
Short-Term Debt Repaid
--500-1,132-127-9.87-82.14
Long-Term Debt Repaid
--1,585-2,597-1,345-2,311-2,717
Lease Payments
-69.43-75.31-85.97-81.95-80.26-76.92
Total Debt Repaid
-2,543-2,085-3,729-1,472-2,321-2,799
Net Debt Issued (Repaid)
-1,184-230.79-1,225559.55492.71-1,358
Repurchase of Common Stock
-----60.8-56.43
Common Dividends Paid
-476.26-632.7-1,042-563.22-553.97-610.49
Other Financing Activities
-4.58493.38-186.05-1,193-114.58-458.73
Financing Cash Flow
-1,665-370.11-2,454-1,196-236.63-2,483

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-26.51-10.360.16-1.2630.391.94
Net Cash Flow
-224.38597.8-1,380-730.54807.36276.97

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,5401,0431,4501,9071,8752,229
Free Cash Flow Growth
18.72%-28.02%-23.98%1.68%-15.89%61.28%
Free Cash Flow Margin
18.90%12.67%17.06%21.98%21.71%28.04%
Free Cash Flow Per Share
1.030.700.971.281.281.48
Levered Free Cash Flow
1,391840.85968.191,3481,5172,531
Unlevered Free Cash Flow
1,403861.161,0061,4001,5572,580
Free Cash Flow After Leases
1,471968.181,3641,8251,7952,153

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.285.518.41-4.05-
Cash Income Tax Paid
1,1501,062993.381,0991,1061,008
Change in Working Capital
48.83-175.63215.24709.88535.211,281